T 1101/00 (Blood coagulation disorders/DAHLBÄCK) of 05.02.2004
- European Case Law Identifier
- ECLI:EP:BA:2004:T110100.20040205
- Date of decision
- 5 February 2004
- Case number
- T 1101/00
- Petition for review of
- -
- Application number
- 92913443.5
- IPC class
- C12Q 1/56
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Method for the diagnosis of blood coagulation disorders
- Applicant name
- DAHLBÄCK, Björn
- Opponent name
- Bio Merieux S.A.
Scripps Research Institute
Akzo Nobel N.V.
Baxter Aktiengesellschaft
Dade Behring Marburg GmbH
Dade Behring Inc.
Roche Diagnostics GmbH
Diagnostica Stago - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108 1973European Patent Convention Art 113(1) 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 123(3) 1973European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973European Patent Convention Art 84 1973
- Keywords
- Appeal by appellant III - admissible
Opportunity to present comments - in opposition - (yes)
Added subject-matter and extension of the scope of protection - (no)
Clarity of claims - (yes)
Sufficiency of disclosure - (yes)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside
2. The case is remitted to the first instance with the order to maintain the patent on the basis of claims 1 to 23 and amended description (pages 2 to 8) filed at the oral proceedings